Status:
RECRUITING
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to provide long-term follow-up care of patients previously enrolled in a vaccine study that involved poxviral vectors. Vectors are sequences of genetic material that can be used to int...
Detailed Description
This protocol aims to provide long-term follow-up and continued use of research specimens of participants previously enrolled on gene transfer or other immunotherapy studies at the National Cancer Ins...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Subjects who received poxviral vectors (vaccinia and/or fowlpox) or other vaccines utilizing gene transfer or any other immunotherapeutic agent through GMB, UOB and LTIB affiliated trials at the National Cancer Institute, as well as subjects at extramural sites receiving these agents as part of a multi-site trial. Available stored specimens obtained from NCI participants in GMB, UOB, and LTIB affiliated protocols may be transferred to this protocol for storage and eventual future research use.
- Subjects must be \>= 18 years of age.
- EXCLUSION CRITERIA:
- Participants unwilling to participate.
- (Please note, participants may participate in this protocol and, at the same time, participate in an active treatment or continuing care study.)
Exclusion
Key Trial Info
Start Date :
September 13 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00451022
Start Date
September 13 2004
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892